This website has been developed by Besins Healthcare (UK) Ltd.

This website has separate sections for healthcare professionals (containing promotional information), and patients who have been prescribed Testogel® (testosterone) within the UK.

Please confirm that:

This website is provided for HCPs in the UK by Besins Healthcare (UK) Ltd.

Diagnosing testosterone deficiency (TD)

Starting the conversation with your patients

Tools for screening

The Androgen Deficiency in Ageing Males (ADAM) questionnaire and the Ageing Males’ Symptoms (AMS) scale are two clinically validated tools, to help quickly evaluate the possible presence, and severity, of TD symptoms.

1. The Androgen Deficiency in Ageing Males (ADAM) questionnaire

The ADAM questionnaire is a clinically validated patient questionnaire to assist in the identification of men over 40 years who may be suffering from TD (a blood test should be used to confirm diagnosis following ADAM screening).1,2 Questionnaires can offer a simple solution for patients that find discussions around their personal health concerns difficult.

‘Yes’ answers to:1

  • question 1 or question 7; or
  • any three other questions;

denotes a positive result and indicates a need for further clinical investigation.

The ADAM questionnaire
has 97% sensitivity for TD3

Request an ADAM questionnaire tear-off pad from your Besins Healthcare representative today.

Review your patients’ symptoms with the ADAM questionnaire.

2. The Ageing Males’ Symptoms (AMS) scale

Interpreting the AMS scale:4

Total score
≤26No/few complaints
27–36Mild
37–49Moderate
50+Severe

The AMS scale has 83% sensitivity for TD3

Review your patients’ symptoms with the AMS scale.

Support patient self-management with the T Track app

Encourage your patients to review their symptoms using the Ageing Males’ Symptom (AMS) scale in the T Track app and monitor their progress over time.

Find out about the T Track app

T Track app available for both iOS and Android phones.

Download on the Apple App Store Get it on Google Play
Support patient self-management with the T Track app

References

  1. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49(9):1239–1242.
  2. Hackett G, Kirby M, Edwards D, et al. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice. J Sex Med. 2017;14(12):1504–1523.
  3. Morley JE, Perry HM, Kevorkian RT, et al. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas. 2006;53(4):424–429.
  4. Moore C, Huebler D, Zimmermann T, et al. The Aging Males’ Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol. 2004;46(1):80–87.

TES/2022/045. February 2023.

Adverse event reporting

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Besins Healthcare (UK) Ltd Drug Safety on 0203 862 0920 or Email: pharmacovigilance@besins-healthcare.com

Where next...